DEXCOM INC (DXCM) Stock Price, Quote, News and Summary
NASDAQ:DXCM - Nasdaq - US2521311074 - Common Stock
DXCM Quote and Key Statistics
DEXCOM INC
NASDAQ:DXCM (1/17/2025, 8:00:01 PM)
After market: 84 -0.38 (-0.45%)84.38
-0.46 (-0.54%)
DXCM Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 17.22% | ||
| ROA | 10.71% | ||
| ROE | 34.4% | ||
| Debt/Equity | 1.26 |
DXCM Performance and Technical Analysis
DXCM Ownership and Analysts
DXCM Latest News and Analysis
Top S&P500 movers in Thursday's session
Top movers analysis one hour before the close of the markets of S&P500 on 2025-01-16: top gainers and losers in today's session.
Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.
Which S&P500 stocks are moving on Thursday?
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.
Nasdaq 100 Movers: TXN, DXCM
About DXCM
Company Profile
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. The company is headquartered in San Diego, California and currently employs 9,600 full-time employees. The company went IPO on 2005-04-14. The firm enables people to take real-time control of health through continuous glucose monitoring (CGM) systems. The firm is engaged in diabetes care technology. Based on the needs of users, caregivers, and providers, the Company works to simplify and improve diabetes management around the world. The firm is primarily focused on the design, development, and commercialization of CGM, systems for the management of diabetes by patients, caregivers, and clinicians around the world. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Dexcom Stelo is designed specifically for people with type II diabetes who do not use insulin and are not at risk for hypoglycemia. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device.
Company Info
DEXCOM INC
6340 Sequence Dr
San Diego CALIFORNIA 92121 US
CEO: Kevin R. Sayer
Employees: 9550
Company Website: https://www.dexcom.com/
Investor Relations: https://investors.dexcom.com
Phone: 18582000200
DXCM Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 88.19 | 211.09B | ||
| ABT | ABBOTT LABORATORIES | 25.11 | 196.83B | ||
| SYK | STRYKER CORP | 32.94 | 146.17B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.81 | 145.41B | ||
| MDT | MEDTRONIC PLC | 16.78 | 112.94B | ||
| BDX | BECTON DICKINSON AND CO | 18.04 | 68.84B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.13 | 41.16B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.08 | 38.72B | ||
| RMD | RESMED INC | 28.92 | 35.20B | ||
| IDXX | IDEXX LABORATORIES INC | 38.29 | 34.33B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 19.55 | 24.25B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 13.89 | 21.81B |